AGENTIC-SYSTEMSMay 18, 20261 min read5 views

Fast-tracking genetic leads to reverse cellular aging

Biologists are leveraging Co-Scientist, an AI assistant, to overcome major bottlenecks in aging research by rapidly identifying genetic targets and analyzing massive experimental datasets to reverse cellular aging.

Two of the biggest bottlenecks in aging research are deciding which genetic pathways to test and making sense of the vast data those experiments produce. Biologists Omar Abudayyeh and Jonathan Gootenberg are using Co-Scientist to help them blast through both.

Their lab runs huge genetic screens that flip thousands of genes on or off then reads how cells respond to these changes. The goal is to find changes that push cells away from senescence – a damaged state linked to aging – and toward a youthful state in tissues such as skin, hair, and muscle.

Co-Scientist is helping on two fronts. First, it generates leads. When the team asked it to trawl the scientific literature for factors that might reverse aging, it scanned tens of thousands of papers, considered a multitude of hypotheses, and ultimately proposed more than 20 novel, plausible genetic factors to test. Lab tests validated a couple Co-Scientist’s hypotheses, with its recommended factors successfully driving cells into a younger state with improved overall function.

Second, Co-Scientist speeds up the follow-through. Once the team has results from a big screen, they have to figure out what the enormous amount of data might mean, and which directions are worth pursuing next. That kind of analysis – trying to connect test results to years of scattered scientific literature – can take a researcher up to six months. Having Co-Scientist analyse their screening data alongside the literature, that work is slashed to just a few days.

Source: Google DeepMind Blog

More in this category

agentic-systems

HG-RAG: Hierarchy-Guided Retrieval-Augmented Generation for Structured Knowledge Graphs

HG-RAG (Hierarchy-Guided Retrieval-Augmented Generation) is a novel framework designed to overcome the limitations of traditional flat RAG systems by traversing hierarchical knowledge graphs, significantly improving multi-hop reasoning and reducing hallucinations in LLMs.

agentic-systems

Enhancing Small Language Models Reasoning through Knowledge Graph Grounding

Researchers have proposed a neuro-symbolic framework that enhances the reasoning capabilities of Small Language Models (SLMs) like Gemma 3 and Llama 3.2 using Knowledge Graphs, achieving up to a 2x performance boost.

agentic-systems

Orchestrating Power Grid Studies with Multi-Agent AI and MCP Servers

This paper explores how Agentic AI and Model Context Protocol (MCP) can support power-grid studies by integrating LLMs with numerical simulation tools under human supervision.

agentic-systems

Human AI Construction of Bayesian Networks for Operational Decision Support -- A Virtual Survey Approach

Researchers propose a new methodology using Large Language Models and AI agents to construct Bayesian Belief Networks, bridging the gap between expert opinion and data-driven learning. The framework is demonstrated through a healthcare decision-making model, revealing key insights into customer behavior.

agentic-systems

Interpretable Language Model for Closed-Loop Type 1 Diabetes Control

Researchers have developed LLM-T1D, a novel approach combining reinforcement learning and large language models to automate insulin delivery for Type 1 Diabetes. The system not only outperforms traditional methods but also explains its decisions in plain language, addressing the 'black-box' challenge in medical AI.

agentic-systems

RegNetAgents: A Multi-Agent Framework for Cross-Network Regulatory Driver Identification in Cancer Genomics

Researchers have introduced RegNetAgents, an AI-oriented multi-agent framework designed to identify regulatory driver candidates across heterogeneous gene networks in cancer genomics. By integrating bulk tumor and single-cell data, the system offers a powerful tool for discovering therapeutic targets in breast and colorectal cancers.